FDA Awards National Priority Vouchers to Psychedelic Drug Developers On April 24, 2026, the U.S. Food and Drug Administration (FDA) announced the issuance of three national priority vouchers to companies …
fda
-
-
FDA Approves First Generic Versions of Farxiga (Dapagliflozin) In a significant move for patient access and healthcare affordability, the U.S. Food and Drug Administration (FDA) approved the first generic versions …
-
FDA Grants First Tentative Approval for Generic Ozempic In a significant move toward expanding affordable access to weight loss and diabetes medications, Apotex Corp. Has received the first U.S. Food …
-
FDA Approves Relacorilant Combination Therapy for Platinum-Resistant Ovarian Cancer On March 25, 2026, the Food and Drug Administration (FDA) approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a first-in-class selective glucocorticoid receptor …
-
New FDA Nutrition Labels: “High In” Warning Outperforms Current Proposal The U.S. Food and Drug Administration’s (FDA) proposed front-of-package (FOP) nutrition labeling system may not be the most effective way …
-
Children’s Ibuprofen Recall: What Parents Necessitate to Know Nearly 90,000 bottles of children’s ibuprofen oral suspension have been voluntarily recalled due to potential contamination with foreign substances, the U.S. Food …
-
FDA Faces Critical Juncture in Approving New Gene Therapies, Warns Former Commissioner Hundreds of individualized treatments for rare diseases could become available over the next decade, but their path to …
-
FDA Infectious Disease Chief Adam Sherwat to Depart Agency WASHINGTON — Adam Sherwat, M.D., director of the Office of Infectious Diseases within the Food and Drug Administration’s (FDA) Center for …
-
Stoke Therapeutics’ Zorevunersen Shows Promise in Treating Dravet Syndrome For children with Dravet syndrome, a rare and severe genetic epilepsy, developmental delays often begin after an initial period of normal …
-
FDA Warns Against Weight Loss Supplements Containing Toxic Yellow Oleander The U.S. Food and Drug Administration (FDA) has issued an expanded warning regarding dietary supplements marketed for weight loss that …